We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
MT-ND4
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • MT-ND4
CANCER OVARIAN CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
OV TCGA OV VALIDATION PROTEIN OV CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Ovarian cancer
Human cancer
Ovary serous cystadenocarcinoma
OVARY SEROUS CYSTADENOCARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

MT-ND4 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)


Stage:

Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 11897.9
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 12747.0
Number of samples 349
Samples
Sample Description pTPM
TCGA-24-1845-01A 42 years, female, white, stage:Stage IIIC, alive, 116 days 45772.4
TCGA-04-1338-01A 78 years, female, white, stage:Stage IIIC, alive, 1418 days 36948.5
TCGA-24-2297-01A 56 years, female, white, stage:Stage IIIC, dead, 1699 days 33820.5
TCGA-04-1331-01A 78 years, female, white, stage:Stage IIIC, dead, 1336 days 32223.1
TCGA-10-0933-01A 77 years, female, white, stage:Stage IIIC, dead, 446 days 30765.3
TCGA-13-1485-01A 48 years, female, white, stage:Stage IV, dead, 629 days 30601.9
TCGA-04-1536-01A 60 years, female, black or african american, stage:Stage IV, dead, 885 days 30327.7
TCGA-04-1361-01A 57 years, female, white, stage:Stage IIIB, alive, 989 days 28721.4
TCGA-24-1471-01A 60 years, female, white, stage:Stage IIIC, alive, 36 days 27695.8
TCGA-24-1565-01A 74 years, female, white, stage:Stage IIIC, dead, 312 days 26472.8
TCGA-61-2088-01A 51 years, female, white, stage:Stage IIIC, alive, 145 days 26429.6
TCGA-24-1105-01A 36 years, female, white, stage:Stage IIIC, dead, 1442 days 26386.2
TCGA-25-2392-01A 75 years, female, white, stage:Stage IV, dead, 31 days 26240.5
TCGA-24-1467-01A 51 years, female, white, stage:Stage IIIC, dead, 3224 days 26075.2
TCGA-13-1403-01A 48 years, female, white, stage:Stage IIIC, dead, 2345 days 26053.9
TCGA-04-1651-01A 53 years, female, white, stage:Stage IIIC, dead, 1102 days 24195.5
TCGA-13-0720-01A 48 years, female, white, stage:Stage IIIC, dead, 1355 days 24053.5
TCGA-25-1318-01A 54 years, female, white, stage:Stage IIIC, dead, 1064 days 23812.9
TCGA-04-1356-01A 62 years, female, white, stage:Stage IIC, dead, 1499 days 23288.1
TCGA-25-1322-01A 62 years, female, white, stage:Stage IV, dead, 91 days 23232.5
TCGA-24-1104-01A 56 years, female, white, stage:Stage IV, dead, 1933 days 23073.6
TCGA-04-1530-01A 68 years, female, white, stage:Stage IIIC, dead, 3622 days 22954.7
TCGA-24-1846-01A 45 years, female, stage:Stage IIIC, alive, 133 days 22268.5
TCGA-24-1425-01A 45 years, female, white, stage:Stage IIIC, alive, 181 days 22101.6
TCGA-57-1586-01A 66 years, female, white, stage:Stage IIIC, alive, 679 days 21885.6
TCGA-24-1430-01A 68 years, female, white, stage:Stage IIIC, dead, 863 days 21748.6
TCGA-29-1688-01A 39 years, female, white, stage:Stage IIIC, dead, 2400 days 21626.9
TCGA-24-1551-01A 53 years, female, white, stage:Stage IIIC, dead, 1579 days 21283.2
TCGA-13-1488-01A 59 years, female, white, stage:Stage IV, dead, 2154 days 21083.5
TCGA-24-1426-01A 43 years, female, white, stage:Stage IIIC, alive, 163 days 20986.5
TCGA-24-2289-01A 68 years, female, white, stage:Stage IV, dead, 2049 days 20982.4
TCGA-23-1120-01A 60 years, female, white, stage:Stage IIIC, alive, 130 days 20976.0
TCGA-24-1923-01A 51 years, female, white, stage:Stage IIIC, dead, 690 days 20964.7
TCGA-24-0968-01A 59 years, female, white, stage:Stage IIIC, dead, 598 days 20748.4
TCGA-23-1118-01A 45 years, female, white, stage:Stage IIIC, alive, 2616 days 20632.7
TCGA-24-2036-01A 50 years, female, white, stage:Stage IIIA, dead, 1947 days 20553.5
TCGA-13-1501-01A 50 years, female, white, stage:Stage IV, dead, 1314 days 20366.6
TCGA-VG-A8LO-01A 55 years, female, black or african american, stage:Stage IV, dead, 24 days 20221.0
TCGA-61-2104-01A 53 years, female, white, stage:Stage IIC, alive, 2338 days 20140.7
TCGA-13-0885-01A 70 years, female, white, stage:Stage IIIC, alive, 3388 days 19900.3
TCGA-24-2254-01A 66 years, female, white, stage:Stage IIIC, dead, 1736 days 19895.6
TCGA-13-0768-01A 73 years, female, white, stage:Stage IIIC, dead, 1784 days 19845.0
TCGA-24-2290-01A 56 years, female, white, stage:Stage IIIC, dead, 1102 days 19823.6
TCGA-61-1910-01A 56 years, female, white, stage:Stage IIC, alive, 1127 days 19795.1
TCGA-25-1321-01A 65 years, female, white, stage:Stage IIIC, dead, 1033 days 19718.2
TCGA-13-1495-01A 60 years, female, white, stage:Stage IIIC, dead, 2749 days 19622.9
TCGA-24-2035-01A 65 years, female, white, stage:Stage IIIC, dead, 857 days 19080.2
TCGA-25-2409-01A 71 years, female, white, stage:Stage IV, dead, 821 days 19024.6
TCGA-13-0714-01A 55 years, female, white, stage:Stage IV, dead, 189 days 18948.0
TCGA-24-2298-01A 55 years, female, white, stage:Stage IIIC, dead, 1620 days 18924.6
TCGA-24-0982-01A 77 years, female, white, stage:Stage IIIC, dead, 679 days 18862.4
TCGA-13-0886-01A 67 years, female, white, stage:Stage IIIC, alive, 4665 days 18835.2
TCGA-23-1030-01A 64 years, female, white, stage:Stage IIIC, alive, 886 days 18537.8
TCGA-OY-A56Q-01A 78 years, female, black or african american, stage:Stage IIA, alive, 576 days 18526.0
TCGA-09-2045-01A 50 years, female, asian, stage:Stage IV, dead, 1069 days 18481.0
TCGA-13-1408-01A 59 years, female, white, stage:Stage IIIC, dead, 1680 days 18404.9
TCGA-24-1928-01A 77 years, female, white, stage:Stage IIIC, dead, 336 days 18352.0
TCGA-20-1687-01A 46 years, female, white, stage:Stage IV, alive, 81 days 18327.7
TCGA-13-1509-01A 64 years, female, white, stage:Stage IV, alive, 2438 days 18291.7
TCGA-13-0724-01A 72 years, female, white, stage:Stage IV, dead, 83 days 18166.2
TCGA-13-1477-01A 49 years, female, white, stage:Stage IV, dead, 1662 days 18136.3
TCGA-23-1119-01A 64 years, female, white, stage:Stage IIIC, alive, 3953 days 18047.4
TCGA-36-1570-01A 49 years, female, white, stage:Stage IIIC, alive, 655 days 18028.9
TCGA-57-1584-01A 47 years, female, white, stage:Stage IIIC, alive, 643 days 18007.4
TCGA-13-1510-01A 62 years, female, white, stage:Stage IIIC, dead, 1359 days 17944.1
TCGA-04-1655-01A 49 years, female, white, stage:Stage IIIB, dead, 1380 days 17770.7
TCGA-24-0979-01A 53 years, female, white, stage:Stage IV, dead, 1264 days 17621.8
TCGA-30-1714-01A 68 years, female, white, stage:Stage IV, dead, 1158 days 17310.4
TCGA-25-1870-01A 59 years, female, white, stage:Stage IIIC, dead, 455 days 17279.2
TCGA-13-0888-01A 78 years, female, white, stage:Stage IIIC, dead, 2811 days 17245.2
TCGA-24-1416-01A 34 years, female, white, stage:Stage IV, alive, 194 days 17081.1
TCGA-30-1853-01A 58 years, female, white, stage:Stage IIIC, dead, 1103 days 17065.3
TCGA-04-1648-01A 57 years, female, white, stage:Stage IIIC, dead, 871 days 16965.6
TCGA-24-1103-01A 50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days 16888.6
TCGA-29-1763-01A 43 years, female, black or african american, stage:Stage IIC, alive, 2032 days 16852.2
TCGA-30-1857-01A 64 years, female, white, stage:Stage IV, dead, 8 days 16800.6
TCGA-24-2293-01A 47 years, female, white, stage:'--, dead, 506 days 16736.3
TCGA-24-2271-01A 55 years, female, asian, stage:Stage IIIC, dead, 962 days 16685.3
TCGA-13-0726-01A 55 years, female, white, stage:Stage IIIC, dead, 949 days 16623.2
TCGA-24-1546-01A 46 years, female, white, stage:Stage IIIC, dead, 1955 days 16585.6
TCGA-13-1404-01A 48 years, female, white, stage:Stage IIIC, alive, 2469 days 16578.1
TCGA-24-2026-01A 79 years, female, white, stage:Stage IIIC, dead, 1059 days 16531.9
TCGA-24-1423-01A 61 years, female, white, stage:Stage IIIC, alive, 190 days 16517.8
TCGA-24-1843-01A 66 years, female, white, stage:Stage IIIC, alive, 106 days 16302.4
TCGA-13-0800-01A 52 years, female, white, stage:Stage IIIC, alive, 2661 days 16154.1
TCGA-10-0928-01A 71 years, female, white, stage:Stage IIIC, dead, 563 days 16054.3
TCGA-25-1329-01A 76 years, female, white, stage:Stage IIIC, dead, 457 days 16023.7
TCGA-25-1313-01A 62 years, female, white, stage:Stage IV, dead, 820 days 15970.4
TCGA-24-1844-01A 64 years, female, white, stage:Stage IIIC, alive, 113 days 15905.5
TCGA-25-1319-01A 73 years, female, white, stage:Stage IIIC, dead, 1977 days 15881.5
TCGA-24-1435-01A 57 years, female, white, stage:Stage IIIC, dead, 1324 days 15768.1
TCGA-31-1950-01A 76 years, female, white, stage:Stage IIIC, alive, 571 days 15757.5
TCGA-13-1411-01A 81 years, female, white, stage:Stage IIIC, dead, 531 days 15735.0
TCGA-13-1505-01A 63 years, female, white, stage:Stage IIIC, alive, 1998 days 15723.0
TCGA-24-2281-01A 68 years, female, white, stage:Stage IIA, alive, 1357 days 15670.4
TCGA-61-2109-01A 40 years, female, white, stage:Stage IIIC, dead, 629 days 15414.5
TCGA-13-1483-01A 61 years, female, white, stage:Stage IIIC, dead, 895 days 15397.7
TCGA-13-0797-01A 49 years, female, white, stage:Stage IIIC, alive, 2121 days 15345.3
TCGA-24-1603-01A 53 years, female, white, stage:Stage IIIB, dead, 2742 days 15288.2
TCGA-04-1365-01A 87 years, female, white, stage:Stage IIIB, alive, 947 days 15226.7
TCGA-09-1673-01A 50 years, female, white, stage:Stage IV, alive, 92 days 15206.0
TCGA-24-1557-01A 49 years, female, white, stage:Stage IIIC, dead, 1213 days 15205.6
TCGA-25-2042-01A 60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days 15197.3
TCGA-23-2077-01A 45 years, female, white, stage:Stage IIIC, alive, 3525 days 15192.5
TCGA-25-1635-01A 71 years, female, white, stage:Stage IIIC, dead, 1583 days 15190.7
TCGA-13-A5FT-01A 67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days 15031.0
TCGA-25-2396-01A 71 years, female, white, stage:Stage IIIC, dead, 92 days 14969.3
TCGA-13-2060-01A 51 years, female, white, stage:Stage IV, alive, 2369 days 14854.0
TCGA-13-1511-01A 52 years, female, asian, stage:Stage IV, dead, 1650 days 14786.3
TCGA-13-1498-01A 73 years, female, white, stage:Stage IIIC, dead, 2012 days 14709.9
TCGA-24-1464-01A 70 years, female, white, stage:Stage IIIC, dead, 379 days 14650.7
TCGA-29-1778-01A 77 years, female, white, stage:Stage IIIC, alive, 454 days 14643.5
TCGA-57-1583-01A 57 years, female, black or african american, stage:Stage IIIC, dead, 346 days 14629.1
TCGA-24-1422-01A 82 years, female, black or african american, stage:Stage IIIC, dead, 23 days 14616.8
TCGA-23-2078-01A 66 years, female, white, stage:Stage IIIC, alive, 2661 days 14472.3
TCGA-24-1427-01A 58 years, female, stage:Stage IIIC, alive, 147 days 14409.9
TCGA-09-1670-01A 57 years, female, white, stage:Stage IIIA, alive, 547 days 14363.0
TCGA-61-2110-01A 56 years, female, white, stage:Stage IIIC, dead, 1354 days 14319.4
TCGA-04-1362-01A 59 years, female, white, stage:Stage IIC, dead, 1348 days 14300.2
TCGA-24-2288-01A 70 years, female, white, stage:Stage IIIC, dead, 25 days 14286.6
TCGA-31-1951-01A 58 years, female, white, stage:Stage IIIC, alive, 684 days 14253.2
TCGA-24-1434-01A 59 years, female, white, stage:Stage IIIC, dead, 568 days 14238.4
TCGA-24-2280-01A 74 years, female, white, stage:Stage IIIC, alive, 2143 days 14194.1
TCGA-61-2097-01A 71 years, female, white, stage:Stage IIC, alive, 1844 days 14170.3
TCGA-25-1323-01A 72 years, female, white, stage:Stage IIIC, dead, 395 days 14157.1
TCGA-13-1496-01A 65 years, female, white, stage:Stage IIIC, dead, 129 days 14037.6
TCGA-30-1866-01A 61 years, female, white, stage:Stage IV, dead, 1114 days 13949.3
TCGA-61-2111-01A 61 years, female, white, stage:Stage IV, alive, 3825 days 13919.7
TCGA-57-1582-01A 50 years, female, white, stage:Stage IIIC, dead, 731 days 13867.7
TCGA-24-2261-01A 76 years, female, white, stage:Stage IIIC, dead, 24 days 13836.9
TCGA-25-1326-01A 61 years, female, white, stage:Stage IIIC, dead, 1249 days 13821.7
TCGA-61-1918-01A 45 years, female, white, stage:Stage IV, dead, 479 days 13703.3
TCGA-13-1492-01A 66 years, female, white, stage:Stage IIIC, dead, 3819 days 13689.6
TCGA-29-2427-01A 60 years, female, white, stage:Stage IIIC, alive, 1900 days 13491.2
TCGA-25-1328-01A 38 years, female, white, stage:Stage IIIC, dead, 2009 days 13486.9
TCGA-13-1512-01A 49 years, female, white, stage:Stage IIIC, alive, 442 days 13480.2
TCGA-04-1347-01A 81 years, female, white, stage:Stage IV, alive, 1919 days 13443.0
TCGA-09-1662-01A 58 years, female, white, stage:Stage IV, dead, 2717 days 13430.7
TCGA-24-1604-01A 66 years, female, white, stage:Stage IIIC, dead, 2688 days 13406.7
TCGA-59-2348-01A 59 years, female, white, stage:Stage IIIC, alive, 5481 days 13297.0
TCGA-13-0762-01A 65 years, female, white, stage:Stage IIIC, alive, 3400 days 13135.9
TCGA-24-1930-01A 53 years, female, white, stage:Stage IIIC, dead, 2467 days 13129.4
TCGA-25-2400-01A 76 years, female, white, stage:Stage IIIC, dead, 1278 days 13109.3
TCGA-24-1413-01A 51 years, female, white, stage:Stage IIIC, alive, 192 days 13102.1
TCGA-13-1405-01A 49 years, female, white, stage:Stage IV, dead, 868 days 13098.3
TCGA-24-1924-01A 65 years, female, white, stage:Stage IIIC, dead, 919 days 13070.6
TCGA-04-1542-01A 52 years, female, white, stage:Stage IIIB, dead, 2561 days 13001.7
TCGA-23-1122-01A 53 years, female, white, stage:Stage IIIC, dead, 1189 days 12957.0
TCGA-13-1409-01A 73 years, female, white, stage:Stage IIIC, dead, 1742 days 12953.3
TCGA-31-1944-01A 47 years, female, white, stage:Stage IIIC, alive, 1386 days 12910.4
TCGA-31-1946-01A 30 years, female, stage:Stage IIIC, alive, 918 days 12897.1
TCGA-23-1116-01A 83 years, female, white, stage:Stage IIIC, dead, 592 days 12843.4
TCGA-24-1616-01A 56 years, female, white, stage:Stage IIIC, dead, 1163 days 12840.4
TCGA-29-1694-01A 45 years, female, white, stage:Stage IIIC, dead, 1187 days 12820.8
TCGA-13-1497-01A 47 years, female, white, stage:Stage IIIC, alive, 3871 days 12772.5
TCGA-25-1320-01A 65 years, female, white, stage:Stage IIIC, dead, 1155 days 12740.1
TCGA-61-2113-01A 53 years, female, white, stage:Stage IIC, dead, 676 days 12695.4
TCGA-36-1571-01A 53 years, female, white, stage:Stage IIIB, dead, 695 days 12639.3
TCGA-13-1407-01A 51 years, female, white, stage:Stage IIIC, alive, 2534 days 12490.0
TCGA-25-1315-01A 50 years, female, white, stage:Stage IIIC, dead, 1583 days 12446.6
TCGA-24-1847-01A 45 years, female, white, stage:Stage IV, alive, 343 days 12370.6
TCGA-36-1568-01A 52 years, female, stage:Stage IIIC, alive, 875 days 12356.2
TCGA-24-2267-01A 58 years, female, white, stage:Stage IIB, dead, 1446 days 12278.0
TCGA-57-1993-01A 56 years, female, white, stage:Stage IIIC, alive, 763 days 12240.6
TCGA-61-1900-01A 51 years, female, black or african american, stage:Stage IIIB, alive, 176 days 12162.3
TCGA-57-1994-01A 63 years, female, white, stage:'--, alive, 761 days 12148.6
TCGA-57-1585-01A 57 years, female, white, stage:Stage IIIC, dead, 53 days 12123.9
TCGA-29-1705-01A 47 years, female, white, stage:Stage IIIC, dead, 555 days 12074.2
TCGA-24-2020-01A 67 years, female, white, stage:Stage IIIC, dead, 4624 days 12032.0
TCGA-25-2398-01A 71 years, female, white, stage:Stage IIIC, dead, 1369 days 11983.3
TCGA-13-0906-01A 50 years, female, white, stage:Stage IIIC, alive, 3619 days 11897.9
TCGA-WR-A838-01A 72 years, female, black or african american, stage:Stage IIIC, dead, 304 days 11881.8
TCGA-25-2399-01A 80 years, female, white, stage:Stage IIIC, dead, 608 days 11879.4
TCGA-61-2101-01A 55 years, female, white, stage:Stage IIIC, dead, 1688 days 11855.5
TCGA-61-1737-01A 42 years, female, white, stage:Stage IV, alive, 1364 days 11844.8
TCGA-25-1623-01A 71 years, female, white, stage:Stage IV, dead, 565 days 11810.7
TCGA-24-1469-01A 71 years, female, white, stage:Stage IIIC, alive, 277 days 11805.7
TCGA-13-0916-01A 49 years, female, white, stage:Stage IIIC, alive, 1785 days 11719.4
TCGA-24-2023-01A 54 years, female, white, stage:Stage IIIA, dead, 1364 days 11706.3
TCGA-10-0937-01A 44 years, female, white, stage:Stage IIIC, dead, 608 days 11693.9
TCGA-23-1023-01A 65 years, female, white, stage:Stage IIIC, alive, 1233 days 11622.2
TCGA-20-1686-01A 75 years, female, white, stage:Stage IIIC, alive, 89 days 11583.7
TCGA-30-1861-01A 74 years, female, white, stage:Stage IIIC, dead, 1058 days 11553.3
TCGA-29-1783-01A 58 years, female, white, stage:Stage IIIC, alive, 220 days 11472.6
TCGA-24-1558-01A 73 years, female, white, stage:Stage IIIC, dead, 594 days 11406.0
TCGA-59-2355-01A 58 years, female, white, stage:Stage IV, dead, 65 days 11348.4
TCGA-23-1109-01A 62 years, female, white, stage:Stage IIIC, dead, 1562 days 11335.3
TCGA-13-0883-01A 61 years, female, white, stage:Stage IIIC, dead, 2097 days 11311.4
TCGA-24-2027-01A 51 years, female, white, stage:Stage IV, dead, 3337 days 11223.1
TCGA-61-1995-01A 43 years, female, white, stage:Stage IIIC, alive, 61 days 11154.9
TCGA-61-1741-01A 76 years, female, white, stage:Stage IIIB, dead, 1024 days 11145.2
TCGA-61-2000-01A 67 years, female, white, stage:Stage IIIC, alive, 441 days 11135.6
TCGA-24-1560-01A 51 years, female, white, stage:Stage IIIC, dead, 1341 days 11113.1
TCGA-24-1419-01A 62 years, female, white, stage:Stage IIIC, alive, 239 days 11044.8
TCGA-61-1998-01A 48 years, female, white, stage:Stage IIIC, alive, 168 days 11016.7
TCGA-04-1519-01A 48 years, female, stage:Stage IIIC, alive, 24 days 10919.1
TCGA-59-2354-01A 63 years, female, white, stage:Stage IIIC, dead, 1046 days 10893.9
TCGA-36-1580-01A 82 years, female, stage:Stage IIIC, dead, 737 days 10704.0
TCGA-24-1552-01A 77 years, female, white, stage:Stage IIIC, dead, 1259 days 10701.1
TCGA-25-1630-01A 73 years, female, white, stage:Stage IIIC, dead, 1162 days 10649.9
TCGA-04-1364-01A 61 years, female, white, stage:Stage IIIC, dead, 1024 days 10649.0
TCGA-61-1725-01A 40 years, female, white, stage:Stage IIIC, alive, 956 days 10598.8
TCGA-24-2038-01A 68 years, female, white, stage:Stage IIIA, dead, 1354 days 10598.2
TCGA-23-1123-01A 59 years, female, white, stage:Stage IIIC, dead, 1018 days 10583.9
TCGA-09-1669-01A 54 years, female, white, stage:Stage IIIA, alive, 928 days 10547.3
TCGA-29-2414-01A 75 years, female, white, stage:Stage IIIC, dead, 2621 days 10411.2
TCGA-23-1111-01A 63 years, female, white, stage:Stage IIIC, alive, 98 days 10404.2
TCGA-29-2428-01A 58 years, female, white, stage:Stage IIIC, alive, 1372 days 10402.9
TCGA-25-2401-01A 64 years, female, white, stage:Stage IIIC, dead, 90 days 10391.8
TCGA-59-2363-01A 40 years, female, asian, stage:Stage IIIA, alive, 165 days 10360.6
TCGA-5X-AA5U-01A 61 years, female, black or african american, stage:Stage IIC, alive, 361 days 10293.2
TCGA-13-1489-01A 70 years, female, white, stage:Stage IIIC, dead, 2553 days 10246.0
TCGA-24-1842-01A 49 years, female, white, stage:Stage IIIC, alive, 253 days 10144.9
TCGA-09-1666-01A 57 years, female, white, stage:Stage IIIC, alive, 1752 days 10124.3
TCGA-25-1317-01A 66 years, female, white, stage:Stage IIIC, dead, 61 days 10032.8
TCGA-31-1953-01A 52 years, female, asian, stage:Stage IIIC, alive, 204 days 9969.7
TCGA-24-1550-01A 49 years, female, white, stage:Stage IIIC, dead, 1249 days 9924.6
TCGA-25-1312-01A 69 years, female, white, stage:Stage IV, dead, 31 days 9907.1
TCGA-24-1428-01A 50 years, female, white, stage:Stage IIIC, alive, 529 days 9898.7
TCGA-36-1581-01A 63 years, female, white, stage:Stage IIC, alive, 751 days 9883.3
TCGA-61-2092-01A 57 years, female, white, stage:Stage IIIC, alive, 1573 days 9875.9
TCGA-29-1695-01A 62 years, female, white, stage:Stage IIIC, dead, 1229 days 9824.9
TCGA-24-1562-01A 67 years, female, white, stage:Stage IIIC, dead, 1384 days 9809.6
TCGA-24-1474-01A 57 years, female, black or african american, stage:Stage IIIC, dead, 676 days 9803.5
TCGA-61-2102-01A 74 years, female, white, stage:Stage IIIC, dead, 197 days 9793.5
TCGA-10-0927-01A 65 years, female, stage:Stage IIIC, dead, 2490 days 9769.5
TCGA-13-1487-01A 74 years, female, white, stage:Stage IV, dead, 681 days 9758.8
TCGA-25-1634-01A 75 years, female, white, stage:Stage IIIC, dead, 1091 days 9754.2
TCGA-59-2350-01A 44 years, female, stage:Stage IV, dead, 679 days 9741.3
TCGA-13-0795-01A 66 years, female, white, stage:Stage IIIC, dead, 619 days 9737.5
TCGA-25-1626-01A 65 years, female, white, stage:Stage IIIC, dead, 518 days 9721.3
TCGA-24-1431-01A 67 years, female, white, stage:Stage IIIC, dead, 583 days 9586.6
TCGA-29-1785-01A 55 years, female, white, stage:Stage IIIC, dead, 1104 days 9584.7
TCGA-61-2003-01A 53 years, female, white, stage:Stage IIIC, alive, 122 days 9578.8
TCGA-59-2351-01A 51 years, female, white, stage:Stage IIIC, alive, 3532 days 9482.3
TCGA-24-2033-01A 87 years, female, white, stage:Stage IIIC, dead, 562 days 9449.9
TCGA-61-1907-01A 63 years, female, white, stage:Stage IIIC, alive, 952 days 9413.5
TCGA-13-0923-01A 74 years, female, white, stage:Stage IIIC, alive, 2547 days 9346.4
TCGA-13-0920-01A 65 years, female, white, stage:Stage IIIC, dead, 1484 days 9287.4
TCGA-24-1424-01A 67 years, female, white, stage:Stage IIIC, alive, 183 days 9250.8
TCGA-61-1733-01A 71 years, female, white, stage:Stage IIIC, alive, 967 days 9183.6
TCGA-29-1710-01A 54 years, female, white, stage:Stage IIIC, dead, 951 days 9179.9
TCGA-13-0765-01A 50 years, female, white, stage:Stage IIIC, dead, 1389 days 9127.2
TCGA-25-1628-01A 67 years, female, white, stage:Stage IIIC, dead, 627 days 9126.2
TCGA-13-0804-01A 73 years, female, white, stage:Stage IIIC, dead, 1073 days 9114.1
TCGA-31-1959-01A 49 years, female, white, stage:Stage IV, alive, 67 days 9084.3
TCGA-36-1577-01A 43 years, female, asian, stage:Stage IIC, alive, 783 days 9079.3
TCGA-24-1553-01A 53 years, female, white, stage:Stage IIIB, dead, 1767 days 9066.3
TCGA-30-1862-01A 65 years, female, white, stage:Stage IV, dead, 186 days 8871.0
TCGA-30-1892-01A 52 years, female, white, stage:Stage IIIC, dead, 1484 days 8867.4
TCGA-13-0725-01A 44 years, female, white, stage:Stage IIIC, dead, 377 days 8853.6
TCGA-61-1919-01A 58 years, female, white, stage:Stage IIIC, dead, 1161 days 8840.4
TCGA-13-1499-01A 56 years, female, white, stage:Stage IIIC, alive, 3500 days 8789.6
TCGA-24-1563-01A 66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days 8749.1
TCGA-31-1956-01A 60 years, female, white, stage:Stage IIIB, alive, 1342 days 8621.2
TCGA-23-1027-01A 48 years, female, white, stage:Stage IIIC, dead, 976 days 8518.4
TCGA-09-2051-01A 42 years, female, white, stage:Stage IIIC, alive, 1919 days 8511.1
TCGA-04-1350-01A 46 years, female, white, stage:Stage IIIC, dead, 1946 days 8476.9
TCGA-24-1417-01A 54 years, female, white, stage:Stage IV, alive, 238 days 8458.2
TCGA-20-1682-01A 56 years, female, white, stage:Stage IIIC, alive, 837 days 8457.0
TCGA-61-2009-01A 65 years, female, white, stage:Stage IIIC, alive, 1212 days 8442.5
TCGA-25-1631-01A 73 years, female, white, stage:Stage IIIC, dead, 9 days 8431.0
TCGA-29-1769-01A 40 years, female, white, stage:Stage IIIC, alive, 699 days 8304.1
TCGA-25-2404-01A 38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days 8260.4
TCGA-13-0891-01A 73 years, female, white, stage:Stage IV, dead, 3128 days 8259.1
TCGA-23-1809-01A 63 years, female, white, stage:Stage IIC, alive, 16 days 8231.5
TCGA-23-1024-01A 52 years, female, white, stage:Stage IV, alive, 468 days 8210.6
TCGA-59-A5PD-01A 55 years, female, black or african american, stage:Stage IC, dead, 624 days 8195.8
TCGA-23-1110-01A 42 years, female, white, stage:Stage IIIC, alive, 1658 days 8119.8
TCGA-13-0887-01A 42 years, female, white, stage:Stage IIIC, dead, 2028 days 8106.4
TCGA-61-2098-01A 62 years, female, white, stage:Stage IIIC, alive, 1993 days 8091.5
TCGA-36-1569-01A 52 years, female, white, stage:Stage IIIC, alive, 885 days 8012.5
TCGA-24-1418-01A 68 years, female, white, stage:Stage IIIC, alive, 243 days 7960.3
TCGA-29-1768-01A 50 years, female, white, stage:Stage IV, dead, 952 days 7959.8
TCGA-61-2002-01A 46 years, female, white, stage:Stage IIIC, alive, 547 days 7885.0
TCGA-61-1724-01A 47 years, female, white, stage:Stage IIIC, dead, 637 days 7843.5
TCGA-13-1410-01A 57 years, female, white, stage:Stage IV, alive, 2464 days 7840.8
TCGA-04-1332-01A 70 years, female, white, stage:Stage IIIC, dead, 1247 days 7826.0
TCGA-04-1514-01A 45 years, female, white, stage:Stage IIIA, dead, 1720 days 7805.1
TCGA-61-1721-01A 38 years, female, white, stage:Stage IV, alive, 338 days 7794.0
TCGA-25-2393-01A 81 years, female, white, stage:Stage IIIC, dead, 1157 days 7792.0
TCGA-13-0730-01A 71 years, female, white, stage:Stage IIIC, dead, 542 days 7723.4
TCGA-29-A5NZ-01A 66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days 7642.7
TCGA-61-1728-01A 59 years, female, white, stage:Stage IV, alive, 848 days 7539.3
TCGA-23-2084-01A 45 years, female, white, stage:Stage IV, dead, 1516 days 7532.7
TCGA-04-1343-01A 72 years, female, white, stage:Stage IV, dead, 361 days 7437.5
TCGA-23-1028-01A 43 years, female, white, stage:Stage IIIC, alive, 1503 days 7404.8
TCGA-29-1762-01A 59 years, female, white, stage:Stage IV, dead, 2634 days 7352.2
TCGA-29-1711-01A 45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days 7320.5
TCGA-24-1850-01A 72 years, female, white, stage:Stage IIIC, alive, 168 days 7278.8
TCGA-29-1761-01A 80 years, female, asian, stage:Stage IIIC, dead, 528 days 7233.1
TCGA-29-1691-01A 51 years, female, white, stage:Stage IIIC, dead, 1470 days 7188.5
TCGA-09-2048-01A 63 years, female, white, stage:Stage IIIC, dead, 138 days 7133.5
TCGA-10-0931-01A 44 years, female, white, stage:Stage IIIC, dead, 1000 days 7125.0
TCGA-29-1693-01A 72 years, female, white, stage:Stage IIIC, alive, 3096 days 7109.2
TCGA-29-1784-01A 55 years, female, white, stage:Stage IIIC, alive, 163 days 6955.8
TCGA-24-2024-01A 72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days 6918.6
TCGA-09-0364-01A 80 years, female, white, stage:Stage IIC, dead, 887 days 6780.8
TCGA-29-1696-01A 43 years, female, white, stage:Stage IIIC, dead, 1032 days 6580.7
TCGA-61-2008-01A 40 years, female, asian, stage:Stage IIC, alive, 932 days 6541.1
TCGA-36-1576-01A 76 years, female, stage:Stage IIIC, alive, 915 days 6511.5
TCGA-09-2054-01A 58 years, female, black or african american, stage:Stage IIIC, dead, 637 days 6505.2
TCGA-59-2352-01A 78 years, female, white, stage:Stage IIIC, dead, 286 days 6427.9
TCGA-29-1690-01A 66 years, female, white, stage:Stage IIIC, dead, 1448 days 6218.3
TCGA-24-0966-01A 78 years, female, black or african american, stage:Stage IIIC, alive, 232 days 6180.5
TCGA-29-1770-01A 54 years, female, white, stage:Stage IIIC, alive, 741 days 6164.4
TCGA-61-1911-01A 55 years, female, white, stage:Stage IIA, alive, 1293 days 6021.5
TCGA-25-1316-01A 55 years, female, white, stage:Stage IIIC, dead, 1279 days 5884.6
TCGA-61-1914-01A 65 years, female, stage:Stage IIIC, alive, 1722 days 5875.9
TCGA-25-1627-01A 73 years, female, white, stage:Stage IIIC, dead, 394 days 5806.5
TCGA-29-1776-01A 63 years, female, black or african american, stage:Stage IIIC, alive, 360 days 5805.7
TCGA-09-0366-01A 55 years, female, white, stage:Stage IIIC, dead, 1757 days 5710.4
TCGA-29-1766-01A 74 years, female, white, stage:Stage IIIC, dead, 1199 days 5527.5
TCGA-29-1774-01A 82 years, female, white, stage:Stage IIIC, alive, 527 days 5433.8
TCGA-24-1549-01A 58 years, female, white, stage:Stage IIIB, dead, 1721 days 5368.9
TCGA-09-0369-01A 56 years, female, white, stage:Stage IIIC, dead, 1082 days 5346.3
TCGA-36-1574-01A 48 years, female, asian, stage:Stage IIIC, alive, 686 days 5206.5
TCGA-23-1107-01A 59 years, female, white, stage:Stage IV, dead, 9 days 5121.5
TCGA-24-1567-01A 54 years, female, white, stage:Stage IIIB, dead, 524 days 5066.0
TCGA-25-1633-01A 64 years, female, white, stage:Stage IIIC, dead, 1891 days 5041.1
TCGA-13-0897-01A 54 years, female, white, stage:Stage IIIC, dead, 2182 days 5015.5
TCGA-30-1718-01A 44 years, female, white, stage:Stage IIIC, dead, 1579 days 5005.3
TCGA-04-1341-01A 85 years, female, white, stage:'--, alive, 33 days 4946.6
TCGA-23-1113-01A 48 years, female, white, stage:Stage IV, dead, 949 days 4918.8
TCGA-61-1738-01A 60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days 4880.6
TCGA-29-2425-01A 60 years, female, white, stage:Stage IIIC, alive, 1977 days 4797.3
TCGA-13-0911-01A 55 years, female, white, stage:Stage IV, dead, 1355 days 4783.6
TCGA-20-1683-01A 65 years, female, white, stage:Stage IIIC, alive, 772 days 4778.6
TCGA-13-1506-01A 45 years, female, white, stage:Stage IIIC, dead, 1039 days 4775.8
TCGA-29-1701-01A 56 years, female, white, stage:Stage IIIC, dead, 515 days 4762.6
TCGA-61-2012-01A 81 years, female, white, stage:Stage IIC, alive, 932 days 4756.3
TCGA-20-0987-01A 61 years, female, white, stage:Stage IIIC, dead, 701 days 4754.0
TCGA-29-1781-01A 69 years, female, white, stage:Stage IIIC, alive, 255 days 4729.5
TCGA-23-1022-01A 67 years, female, white, stage:Stage IIIC, dead, 1511 days 4690.0
TCGA-29-1697-01A 62 years, female, white, stage:Stage IIIC, dead, 949 days 4668.6
TCGA-30-1891-01A 61 years, female, white, stage:Stage IIIC, dead, 914 days 4333.3
TCGA-13-0727-01A 71 years, female, white, stage:Stage IIIC, dead, 462 days 4322.4
TCGA-25-1632-01A 68 years, female, white, stage:Stage IV, dead, 1799 days 4316.8
TCGA-30-1860-01A 58 years, female, white, stage:Stage IIIC, dead, 1366 days 4260.4
TCGA-09-0367-01A 67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days 4259.3
TCGA-13-0924-01A 45 years, female, white, stage:Stage IV, alive, 2614 days 3882.2
TCGA-10-0938-01A 80 years, female, white, stage:Stage IIIC, dead, 636 days 3793.4
TCGA-29-1703-01A 56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days 3592.0
TCGA-29-1777-01A 47 years, female, white, stage:Stage IIIC, alive, 374 days 3475.1
TCGA-24-1544-01A 71 years, female, black or african american, stage:Stage IIIC, dead, 820 days 3268.2
TCGA-13-0766-01A 42 years, female, white, stage:Stage IIIC, dead, 1725 days 2844.6
TCGA-25-1877-01A 81 years, female, white, stage:Stage IIIC, dead, 730 days 2525.0
TCGA-20-0991-01A 78 years, female, white, stage:Stage IIB, alive, 797 days 2081.5
TCGA-13-1507-01A 77 years, female, white, stage:Stage IIIC, dead, 1993 days 1412.3
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

MT-ND4 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 8920.47
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 7690.4
Number of samples 81
Samples
Sample Description pTPM
DO46518 62 years, female, NA, stage:III, alive, 2960 days 29484.7
DO46428 59 years, female, NA, stage:IV, alive, 2644 days 21401.1
DO46546 73 years, female, NA, stage:III, dead, 1889 days 18458.3
DO46408 56 years, female, NA, stage:III, dead, 489 days 16440.0
DO46400 70 years, female, NA, stage:III, dead, 719 days 16182.6
DO46404 55 years, female, NA, stage:III, dead, 690 days 15146.3
DO46329 52 years, female, NA, stage:III, dead, 1699 days 13864.1
DO46566 78 years, female, NA, stage:III, dead, 673 days 13102.8
DO46438 55 years, female, NA, stage:IV, alive, 2227 days 12191.6
DO46331 72 years, female, NA, stage:III, dead, 612 days 12173.1
DO46382 62 years, female, NA, stage:IV, dead, 311 days 11710.8
DO46561 52 years, female, NA, stage:III, dead, 195 days 11516.5
DO46513 54 years, female, NA, stage:IV, dead, 1883 days 11143.7
DO46458 67 years, female, NA, stage:IV, alive, 3787 days 10667.6
DO46378 59 years, female, NA, stage:III, alive, 843 days 10554.0
DO46528 56 years, female, NA, stage:III, alive, 6139 days 10420.2
DO46336 70 years, female, NA, stage:IV, dead, 664 days 10135.7
DO46493 62 years, female, NA, stage:IV, alive, 839 days 9918.6
DO46606 73 years, female, NA, stage:III, alive, 804 days 9821.1
DO46538 57 years, female, NA, stage:III, dead, 1527 days 9639.6
DO46468 67 years, female, NA, stage:III, alive, 2776 days 9112.6
DO46586 55 years, female, NA, stage:III, dead, 1019 days 8728.3
DO46348 58 years, female, NA, stage:IV, dead, 287 days 8607.4
DO46340 62 years, female, NA, stage:III, dead, 616 days 8547.2
DO46372 39 years, female, NA, stage:III, dead, 1326 days 8473.5
DO46398 66 years, female, NA, stage:III, alive, 437 days 8405.7
DO46332 56 years, female, NA, stage:III, dead, 689 days 8310.8
DO46551 58 years, female, NA, stage:III, dead, 1055 days 7716.4
DO46588 74 years, female, NA, stage:III, dead, 438 days 7612.4
DO46360 58 years, female, NA, stage:IV, dead, 1759 days 7591.9
DO46602 74 years, female, NA, stage:III, dead, 205 days 7483.3
DO46328 52 years, female, NA, stage:III, dead, 972 days 7480.4
DO46342 67 years, female, NA, stage:III, dead, 1398 days 7476.1
DO46533 46 years, female, NA, stage:III, alive, 3667 days 7467.5
DO46386 49 years, female, NA, stage:III, dead, 1162 days 7414.8
DO46597 60 years, female, NA, stage:III, dead, 393 days 7353.3
DO46571 61 years, female, NA, stage:III, dead, 243 days 7352.2
DO46362 61 years, female, NA, stage:III, dead, 1639 days 7316.6
DO46384 55 years, female, NA, stage:III, dead, 614 days 7286.5
DO46396 64 years, female, NA, stage:III, dead, 583 days 7270.2
DO46370 54 years, female, NA, stage:III, dead, 1727 days 6928.8
DO46364 45 years, female, NA, stage:III, dead, 806 days 6881.2
DO46344 46 years, female, NA, stage:III, dead, 642 days 6733.1
DO46354 73 years, female, NA, stage:III, dead, 843 days 6624.6
DO46560 45 years, female, NA, stage:IV, dead, 286 days 6605.2
DO46334 77 years, female, NA, stage:III, dead, 496 days 6556.1
DO46358 60 years, female, NA, stage:III, dead, 423 days 6529.6
DO46568 66 years, female, NA, stage:III, dead, 320 days 6495.5
DO46523 52 years, female, NA, stage:IV, alive, 1873 days 6120.6
DO46330 60 years, female, NA, stage:III, dead, 684 days 6094.5
DO46443 59 years, female, NA, stage:III, dead, 2464 days 5739.6
DO46327 54 years, female, NA, stage:III, dead, 184 days 5680.4
DO46346 54 years, female, NA, stage:III, dead, 1187 days 5530.4
DO46392 48 years, female, NA, stage:III, dead, 628 days 5522.6
DO46463 49 years, female, NA, stage:III, dead, 2451 days 5471.8
DO46325 54 years, female, NA, stage:III, dead, 477 days 5461.0
DO46448 45 years, female, NA, stage:III, dead, 654 days 5297.7
DO46508 50 years, female, NA, stage:III, dead, 2101 days 5262.0
DO46326 51 years, female, NA, stage:III, dead, 701 days 5230.0
DO46611 52 years, female, NA, stage:III, dead, 734 days 5227.0
DO46390 65 years, female, NA, stage:III, dead, 374 days 5009.2
DO46376 58 years, female, NA, stage:III, dead, 1430 days 4970.4
DO46436 58 years, female, NA, stage:III, alive, 3193 days 4880.7
DO46350 66 years, female, NA, stage:III, dead, 886 days 4783.0
DO46368 57 years, female, NA, stage:III, dead, 2879 days 4757.4
DO46374 69 years, female, NA, stage:III, dead, 1409 days 4676.8
DO46338 59 years, female, NA, stage:III, dead, 596 days 3933.4
DO46394 61 years, female, NA, stage:IV, dead, 1039 days 3745.1
DO46366 65 years, female, NA, stage:III, dead, 2054 days 3656.0
DO46402 77 years, female, NA, stage:III, dead, 511 days 3423.1
DO46388 74 years, female, NA, stage:III, dead, 413 days 3339.5
DO46581 66 years, female, NA, stage:III, dead, 408 days 3333.2
DO46352 60 years, female, NA, stage:III, dead, 677 days 3324.0
DO46432 56 years, female, NA, stage:III, alive, 2218 days 3002.0
DO46412 64 years, female, NA, stage:III, dead, 597 days 2970.0
DO46333 58 years, female, NA, stage:III, dead, 359 days 2955.2
DO46576 75 years, female, NA, stage:III, alive, 133 days 2165.3
DO46380 51 years, female, NA, stage:III, dead, 1423 days 2041.1
DO46591 58 years, female, NA, stage:III, dead, 195 days 1674.9
DO46453 66 years, female, NA, stage:III, dead, 3294 days 1666.2
DO46356 68 years, female, NA, stage:III, dead, 911 days 1650.6
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples 108
Samples
Sample ID Sample type nRPX
e3ebe010-cd31-4b5d-8fcb-b7103b_D2 Tumor N/A
1556af7e-c2ae-4fce-9aae-87c459_D1_D2 Normal N/A
21efd60f-6a31-4b98-9477-16a905_D2 Normal N/A
b22659b9-e12c-4725-a7db-a833de_D1_D2 Normal N/A
3946a96c-e0ae-442f-83b4-a9350e_D2 Tumor N/A
285fed94-1495-448e-879b-b55de9_D2 Tumor N/A
d109a3c0-350e-47f5-bda0-61899c_D2 Tumor N/A
a583d3ff-8165-43e9-b764-23b7ef_D1_D2 Normal N/A
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2 Tumor N/A
6e209757-a7f4-45af-b5f3-2ebc02_D2 Normal N/A
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2 Normal N/A
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2 Tumor N/A
91b287fd-eadb-442d-abcd-20b741_D2 Tumor N/A
a8853382-b726-4ce8-98d5-ca89df_D2 Tumor N/A
eb3f3494-7057-4afe-b212-e6e9a3_D2 Tumor N/A
2f901c90-617e-46da-9fac-d68369_D2 Tumor N/A
41d0619e-b299-42e2-ac32-29e784_D2 Tumor N/A
efc971f8-54c5-4531-a792-705ecf_D2 Tumor N/A
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2 Tumor N/A
05387aad-2a1f-42c2-8d6f-950598_D3 Tumor N/A
558333b0-ea23-4303-9e3c-4932b1_D2 Tumor N/A
d38f40fb-dd78-43b2-8b7b-4b6977_D2 Tumor N/A
1c9145ad-1981-4871-aa7e-8b11de_D2 Tumor N/A
318d53c3-216b-4de1-a098-77d6dd_D2 Tumor N/A
3a380577-c134-47ba-a1ce-988d7c_D2 Tumor N/A
7d953d1d-84b6-4ecd-b1d7-1ed865_D2 Tumor N/A
256ac9f5-1e19-44b4-92fb-fef3fc_D2 Tumor N/A
46c73531-f531-4ec3-97fe-b39d9d_D2 Tumor N/A
a03d1103-b809-42c4-ad5c-5aff58_D2 Tumor N/A
6530147a-efe9-4df6-ac2f-03ece3_D2 Tumor N/A
0745488e-0bfb-4d1f-8228-dedf76_D1_D2 Normal N/A
e23eb014-69c1-460a-b9d4-9786c8_D2 Normal N/A
7069e990-4a4e-4984-a66d-4d835a_D2 Tumor N/A
627e6e36-3dca-4ee5-9755-6f3510_D2 Tumor N/A
3e746bea-ed68-40e6-b348-6ddf08_D2 Normal N/A
1772e913-f62e-446a-8cf3-720348_D2 Tumor N/A
e9d416e7-f661-400a-896e-388545_D2 Tumor N/A
e6850782-fd2a-4c53-b682-1852fe_D2 Tumor N/A
79b60f32-6cca-4cb6-9a1e-22a3ac_D2 Tumor N/A
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2 Tumor N/A
8e17b45e-6a06-4e4e-913d-7b1edb_D2 Tumor N/A
f6c215ea-5381-4521-bb61-be8e97_D2 Tumor N/A
2ed8beb2-bc63-4bad-b5fe-1916a0_D2 Tumor N/A
2563cb02-d58a-4286-8634-7502cd_D2 Tumor N/A
50997c44-1c8b-4d34-b535-4a6cc2_D2 Tumor N/A
42d860a3-8a0c-4c44-a09a-9ad8cf_D2 Tumor N/A
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2 Tumor N/A
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2 Normal N/A
69d552be-7cb2-4bb4-b602-a27b3e_D2 Tumor N/A
51a4ce2f-4166-4c6b-a7e0-942d0a_D2 Tumor N/A
10c2d629-0287-4511-ac25-f29031_D2 Tumor N/A
2224c03f-b7b1-4368-887e-2b4cdf_D2 Tumor N/A
2b73e01c-347a-4dae-a71d-752aeb_D2 Normal N/A
76e77c6b-c80e-4391-bdbb-e1dcea_D2 Tumor N/A
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2 Tumor N/A
eb0a53df-7620-4024-8d2d-051142_D2 Tumor N/A
80873a0c-1f40-4d51-bab1-3f2071_D2 Tumor N/A
340a3769-3031-41ae-bb08-a2f696_D2 Normal N/A
2433b136-fc7b-4cea-b958-bc6efb_D2 Tumor N/A
994f9b8e-46cb-413f-8ec8-2c2fed_D2 Normal N/A
2115808b-6a0d-49bc-a8d7-b83bde_D2 Tumor N/A
5ea22f5e-307b-491d-801f-8b7fa6_D2 Tumor N/A
af95e2c6-25c4-4ab8-bf06-3e15ff_D2 Tumor N/A
49bd51fe-48a1-4828-b66e-b30c38_D2 Tumor N/A
08296da7-70ea-44df-8646-09f2cc_D2 Tumor N/A
31c15e30-21d4-4843-bd4a-9cd0d8_D2 Normal N/A
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2 Normal N/A
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2 Tumor N/A
3fbf076a-824b-4eac-b6dc-bf5e59_D2 Normal N/A
1b2ab076-c72f-4bbe-b9f9-657d24_D2 Tumor N/A
2b4ce90c-8036-4207-ac3e-54a76f_D2 Tumor N/A
c17b0ff9-9057-4848-a0cc-abb25f_D2 Tumor N/A
52c064a7-78d9-4a1a-85b4-27c6d1_D2 Tumor N/A
15524912-685a-47ce-a824-567848_D2 Tumor N/A
bd266bdd-12e4-42cb-9c49-911bfc_D2 Tumor N/A
927f0958-db5a-4bc5-92b7-2a3695_D2 Tumor N/A
d4791079-c826-4fc7-9d9b-ee20ba_D2 Tumor N/A
35a345a4-e954-4c81-ae3f-7797cd_D2 Tumor N/A
0cc794c3-5bf5-4621-b238-58a0f6_D2 Tumor N/A
3490835c-c004-45ed-91f3-7c206f_D2 Tumor N/A
a3a26070-fb84-406a-8280-d555e6_D2 Normal N/A
161317f3-1a39-438e-af45-cd2502_D2 Tumor N/A
fe83e13f-9754-403b-8f74-d6caf8_D2 Tumor N/A
1db5574d-aca7-403c-8100-6e705f_D2 Normal N/A
4ccb249a-6722-491e-97e9-e3b4e7_D2 Tumor N/A
9b90eb78-2f50-4aeb-b010-d642f9_D2 Tumor N/A
b9c1f22e-61f7-45ed-b3b4-5094c7_D2 Normal N/A
8d78194e-fbef-4819-a7b5-b73ae9_D2 Tumor N/A
7edfd606-4bee-4529-9fec-1ca7f0_D2 Normal N/A
3d3e1888-d67e-4c69-ba83-112d0f_D2 Tumor N/A
28d0abdb-f682-4bd3-9425-a9c508_D2 Tumor N/A
61f76fe6-a1c6-41b8-bdc2-2f9209_D2 Normal N/A
6319b36b-533c-4e86-8e12-80552e_D3 Tumor N/A
0c87932d-b6fd-4eb5-b86a-a34d07_D2 Tumor N/A
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2 Tumor N/A
092af714-b97a-457c-b0e9-8c20e8_D2 Normal N/A
62f5840e-6cd7-4200-b651-645e53_D2 Tumor N/A
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2 Tumor N/A
347e379b-77c0-4dd3-aa25-18c9d1_D2 Tumor N/A
5c3971ee-87c7-4dff-b66e-f18892_D2 Tumor N/A
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3 Tumor N/A
27f3ca2d-a86f-479d-8e7e-5307c7_D2 Tumor N/A
a65d8e76-640f-4341-a561-afbb57_D2 Normal N/A
fbb41c94-aabd-49cc-90b2-882c3e_D2 Tumor N/A
1a10c200-3895-4648-b951-94f99f_D2 Tumor N/A
9e0d47e0-f633-468b-b82b-4d752d_D2 Tumor N/A
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2 Tumor N/A
9c8e78bf-b03e-4ba0-9909-5ff070_D2 Tumor N/A
Show allShow less
OVARIAN CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA053928
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cystadenocarcinoma, serous, NOS
Carcinoma, NOS
Cystadenocarcinoma, serous, NOS
Cystadenocarcinoma, mucinous, NOS
Carcinoma, endometroid

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org